Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon |
|
Bewertung der Leuchtdioden-Fluoreszenz-Mikroskopie im Vergleich zu konventioneller Fluoreszenz-Mikroskopie, Lichtmikroskopie und Polymerase-Kettenreaktion zur Diagnose von Plasmodium falciparum-Infektionen in Gabun |
|
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans |
|
Characterization of Plasmodium falciparum mature gametocytes lifespan, immunogenicity and susceptibility to novel compounds |
|
Characterization of the epidemiology of major infectious diseases in the rural region of Tsamba-Magotsi in la Ngounie province in Gabon |
|
Charakteristika der Malaria bei Patienten der Pädiatrie des Albert Schweitzer Hospitals in den Jahren 1994-2000 |
|
A clinical phase III comparative, randomised, clinical trial to assess the safety and efficacy of a fixed dose of oral pyronaridine-artesunate granule formulation (60 20) (paediatric Pyramax®) versus artemether-lumefantrine (Coartem®) crushed tablets in infants and children with acute uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon |
|
Co-detection of Panton-Valentine Leukocidin and cotrimoxazole resistance in Staphylococcus aureus: Implications for HIV-patients' care |
|
Community-associated staphylococcus aureus from sub-saharan Africa and Germany: a cross-sectional geographic correlation Study |
|
Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression |
|
Determinants of tuberculosis in Lambaréné and barriers towards successful antituberculous treatment |
|
Development of a new method to quantify ex vivo erythrophagocytosis by autologous monocytes |
|
Development of a Western blot method for a semiquantitative determination of the antibody concentration against the malaria vaccine GMZ2 - a fusion protein of MSP3 and GLURP |
|
Differentialblutbild, Symptome und Prävalenz von Infektionen mit Plasmodium falciparum, Loa loa und Mansonella perstans bei Krankenhauspatienten in Fougamou, Gabun |
|
Distribution of Knop blood group antigens and association of Triggering receptor expressed on myeloid cells 1 (TREM-1) gene variants in Ghanaian children with malaria |
|
Effekt von antihelminthischer Behandlung auf die Impfimmunogenität in einer für Geohelminthen sehr anfälligen Population |
|
Einflussfaktoren auf die Inzidenzdichte klinischer Malaria von Säuglingen und Kleinkindern in Lambaréné, Gabun |
|
Endemic infectious diseases in pregnant women in central African Gabon Epidemiology and Evaluation of new Interventions |
|
Entwicklung einer neuen Methode zur ex vivo Quantifizierung der autologen Erythrophagozytose |
|
Epidemiologische Analyse der Malariaprävalenz schwangerer Frauen in einem zentralafrikanischen Endemiegebiet |
|
Etablierung einer Multiplex-qPCR zur Detektion einer Deletion des pfhrp2-Gens in Plasmodium falciparum |
|
Extending the spectrum of antimalarial treatment Artemisinin combinations for the treatment of rare Plasmodium species infections and the development of dyes as antimalarials |
|
Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia |
|
Hepatitis E virus superinfection and clinical progression in hepatitis B patients |
|
Host and parasite factors influencing clinical malaria in African children |
|
Immunität gegen Malaria |
|
In vitro Aktivitätsbestimmung von experimentellen Chemotherapeutika gegen Plasmodium falciparum in Lambaréné, Gabun |
|
influence of maternal Loa loa and Mansonella perstans infection on the distribution of Th1, Th17 and T regulatory T cell subsets in cord blood |
|
Investigation of Factors Influencing var Gene Expression in Plasmodium falciparum Parasites from Acute and Chronic Infections |
|
Investigation of lectin complement proteins in urinary schistosomiasis and visceral leishmaniasis |
|
Investigation of the effector mechanisms of Natural Killer Cells against Plasmodium falciparum-infected erythrocytes |
|
Malaria-Impfstoffkandidat GMZ2; Beurteilung der Sicherheit und der humoralen Immunantwort im Rahmen einer Phase-Ib-Studie in Gabun |
|
Nachweisgrenzen der Mikroskopie von Plasmodium falciparum in einem endemischen Malariagebiet Zentralafrikas |
|
Natural killer cell transcriptome in patients treated with multi-drug-therapy and host genetic factors influencing leprosy outcome |
|
Natürlich erworbene Antikörper gegen einen Malariaimpfstoff bei Guahibo und Piaroa im venezolanischen Amazonas |
|
Prevalence of parasitic co-infections and their association with the Hb-level and the anthropometric status in children aged 1-5 years in Lambaréné, Gabon |
|
Pronounced regulatory T cell activity in human schistosomiasis differences in T cell proliferation and cytokine responses before and after treatment with Praziquantel |
|
Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa |
|
risk to import ESBL-producing Enterobacteriaceae and Staphylococcus aureus through chicken meat trade in Gabon |
|
Social dynamics of biomedical research in a sub-Saharan African country.Patterns of participation in clinical research at the Medical Research Unit of the Albert Schweitzer Hospital at Lambaréné, Gabon |
|
Soziale Dimensionen biomedizinischer Forschung in einem südlich der Sahara gelegenen afrikanischen Land. Wahrnehmungen und Einstellungen von Studienteilnehmern der Medical Research Unit des Albert Schweitzer Krankenhauses in Lambaréné, Gabun |
|
Tropical medicine at the University of Tübingen |
|
Untersuchung der Effektormechanismen von Natürlichen Killerzellen gegenüber Plasmodium falciparum infizierten Erythrozyten |
|
Vergleich der Adjuvanzien AS01 und AS02 im Rahmen einer doppelt blinden, randomisierten Studie des Malariavakzinekandidaten RTS,S bei Kindern in Gabun Klinische Sicherheit und Verlauf der Laborwerte über einen Zeitraum von 14 Monaten |
|
Vermehrte regulatorische T-Zell-Aktivität in menschlicher Bilharziose |
|
Wirksamkeit von Mefloquin als intermittierende präventive Behandlung der Malaria in der Schwangerschaft gegen Schistosoma haematobium-Infektionen in Gabun |
|